MarcusDasilvaGoncalvesMDPhD

Endocrinology • New York, NY

Diabetes, Lipid Metabolism

Assistant Professor

Join to view full profile

Dr. Goncalves is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goncalves' full profile

Already have an account?

Office
222 E 41st Street
23rd Floor
New York, NY 10016
Phone+1 212-481-1350

Summary

Dr. Marcus Goncalves is an endocrinologist in New York, NY. He received his medical degree from the University of Pennsylvania and has been in practice 5 years. He specializes in muscle health, diabetes, low testosterone, and lipid metabolism.

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2018
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012

Certifications & Licensure

NY State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

American Society of Clinical Investigation 2024

Publications & Presentations

PubMed

3 citations
Diet and Cancer Metabolism.
Jason W Locasale, Marcus D Goncalves, Maira Di Tano, Guillermo Burgos-Barragan
Cold Spring Harbor Perspectives in Medicine. 2024-12-02
4 citations
AMPK as a mediator of tissue preservation: time for a shift in dogma?
Henning Tim Langer, Maria Rohm, Marcus DaSilva Goncalves, Lykke Sylow
Nature Reviews. Endocrinology. 2024-09-01
Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer.
Henning Tim Langer, Shakti Ramsamooj, Ezequiel Dantas, Anirudh Murthy, Mujmmail Ahmed
Acta Physiologica. 2024-08-01

Journal Articles

Publisher Correction: Suppression of Insulin Feedback Enhances the Efficacy of PI3K Inhibitors
Siddhartha Mukherjee, Marcus D Goncalves, Mark A Rubin, Nature
Suppression of Insulin Feedback Enhances the Efficacy of PI3K Inhibitors
Marcus D Goncalves, Siddhartha Mukherjee, Mark A Rubin, Nature

Lectures

Tumor Biology of Breast and Prostate Cancers
ENDO 2019 - New Orleans, LA - 3/23/2019
Fenofibrate Prevents Skeletal Muscle Loss in Mice with Lung Cancer
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/17/2018

Press Mentions

Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24thJuly 11th, 2024
Colon Cancer Risk High with High Fructose Corn Syrup ConsumptionApril 14th, 2019
Cancer Tumours in the Gut Feed off Sugary Drinks, New Study ShowsMarch 23rd, 2019
Join now to see all